Cancer

Low-risk prostate lesions: An evidence review to inform discussion on losing the “cancer” label – Caitlin R. Semsarian et al.

2023-03-01T12:28:26+11:00Cancer, Disease labels, Expanding disease definitions, Overdiagnosis, Overtreatment, Prostate cancer, Publications|

This review found robust evidence to inform discussion of possible recalibration of diagnostic thresholds, or use of alternative labels, for low-risk prostate cancer. RCTs and cohort studies demonstrate that active surveillance is a safe option for very low-risk and low-risk prostate cancers, with extremely low [...]

Exploring the Integration of Environmental Impacts in the Cost Analysis of the Pilot MEL-SELF Trial of Patient-Led Melanoma Surveillance – Jake T. W. Williams et. al

2023-01-11T11:28:34+11:00Cancer, Carbon neutral, Patient-led surveillance, Publications|

Human health is intrinsically linked with planetary health. But planetary resources are currently being degraded and this poses an existential threat to human health and the sustainability of our healthcare systems. The aims of this study were to (1) describe an approach to integrate environmental [...]

Considerations for Evaluating the Introduction of New Cancer Screening Technology: Use of Interval Cancers to Assess Potential Benefits and Harms – Rachel Farber et. al

2023-01-11T11:24:25+11:00Cancer, Overdiagnosis, Publications, Screening|

This framework focuses on the importance of the consideration of the downstream intermediate and long-term health outcomes when a change to a screening program is introduced. The authors present a methodology for utilising the relationship between screen-detected and interval cancer rates to infer the benefits [...]

Discussion of costs and financial burden in clinical practice: A survey of medical oncologists in Australia – Anupriya Agarwal et. al

2023-01-11T11:17:41+11:00Cancer, Publications, Screening, Shared decision making|

A diagnosis of cancer is associated with significant physical, psychological and financial burden. Including costs of cancer is an important component of shared decision making. Doctors bear a responsibility towards educating patients about the financial aspects of care. Multiple organisations have advocated for price transparency [...]

Including Information on Overdiagnosis in Shared Decision Making: A Review of Prostate Cancer Screening Decision Aids – Thanya I. Pathirana et. al

2023-01-11T11:13:18+11:00Cancer, Overdiagnosis, Prostate cancer, Publications, Shared decision making|

Most patient decision aids for prostate cancer screening lacked important information on overdiagnosis. Specific guidance is needed on how to communicate the risks of overdiagnosis in decision aids, including appropriate content, terminology and graphical display.

Go to Top